📰 Dave Helsel News
Dave Helsel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dave Helsel. Real-time updates on events, politics, business and more.
May 2, 2023
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Based on an average daily trading volume, of 336,700 shares, the […]
April 30, 2023
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Currently, 2.0% of the shares of the company are sold short. Based on an […]
April 29, 2023
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a decrease of 18.2% from the March 31st total of 923,300 shares. Approximately 2.0% of the company’s stock are short sold. Based on […]
April 21, 2023
Raymond James downgraded shares of AngioDynamics (NASDAQ:ANGO – Get Rating) from a strong-buy rating to an outperform rating in a report released on Monday morning, Marketbeat.com reports. The brokerage currently has $13.00 price target on the medical instruments supplier’s stock, down from their previous price target of $14.00. Separately, StockNews.com assumed coverage on shares of […]
April 19, 2023
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Equities research analysts at Zacks Research lowered their FY2023 EPS estimates for AngioDynamics in a research report issued to clients and investors on Wednesday, April 12th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.06) per share for the year, down from […]
April 7, 2023
AngioDynamics (NASDAQ:ANGO – Get Rating) had its price target trimmed by Raymond James from $22.00 to $14.00 in a research report report published on Monday, Benzinga reports. The firm currently has a strong-buy rating on the medical instruments supplier’s stock. Separately, StockNews.com initiated coverage on shares of AngioDynamics in a report on Thursday, March 16th. […]
April 6, 2023
AngioDynamics (NASDAQ:ANGO – Get Rating) had its price objective cut by Raymond James from $22.00 to $14.00 in a report published on Monday morning, Benzinga reports. They currently have a strong-buy rating on the medical instruments supplier’s stock. Separately, StockNews.com assumed coverage on AngioDynamics in a research note on Thursday, March 16th. They issued a […]
April 5, 2023
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Equities researchers at KeyCorp lowered their Q4 2023 earnings per share estimates for AngioDynamics in a research report issued on Thursday, March 30th. KeyCorp analyst M. Mishan now anticipates that the medical instruments supplier will post earnings of $0.04 per share for the quarter, down from their prior […]
April 5, 2023
AngioDynamics (NASDAQ:ANGO – Get Rating) had its price target lowered by equities researchers at Raymond James from $22.00 to $14.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical instruments supplier’s stock. Raymond James’ price objective would indicate a potential upside […]
April 2, 2023
AngioDynamics (NASDAQ:ANGO – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided EPS guidance of -$0.06–$0.01 for the period, compared to the consensus EPS estimate of -$0.01. The company issued revenue guidance of $338.00 million-$342.00 million, compared to the consensus revenue estimate of $342.47 million. Analyst Upgrades and Downgrades A number […]